List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 96 studies with search of:   "Octreotide"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Preoperative Octreotide Treatment of Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide;   Procedure: Direct surgery for acromegaly;   Drug: Preoperative octreotide treatment before transsphenoidal surgery for acromegaly
2 Active, not recruiting RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
Conditions: Neuroendocrine Carcinoma;   Islet Cell Carcinoma
Interventions: Drug: RAD001;   Drug: Octreotide Depot
3 Recruiting Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide Implant;   Drug: Sandostatin LAR Depot
4 Recruiting GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma
Condition: Advanced Hepatocellular Carcinoma
Interventions: Drug: Octreotide-LAR, Lanreotide Autogel;   Drug: Octreotide-LAR or Lanreotide Autogel;   Other: Locoregional treatments
5 Completed The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed
Conditions: Portal Hypertension;   Cirrhosis;   Hematemesis;   Melena
Interventions: Drug: Terlipressin;   Drug: Octreotide
6 Recruiting Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
Condition: Prader-Willi Syndrome
Intervention: Drug: Octreotide
7 Recruiting Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Interventions: Drug: Sandostatin LAR;   Drug: Sandostatin LAR
8 Completed Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide acetate
9 Completed A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.
Conditions: Diarrhea;   HIV Infections
Intervention: Drug: Octreotide
10 Completed Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
Conditions: Liver;   Cancer
Interventions: Drug: Thalidomide, alpha interferon;   Drug: Thalidomide, interferon, Octreotide
11 Completed Acute Application of Pegvisomant and Octreotide in Acromegaly
Condition: Acromegaly
Interventions: Drug: pegvisomant;   Drug: combination with somatostatin analogue octreotide;   Drug: combination with dopamine agonist cabergoline
12 Completed The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction
Conditions: Type 2 Hepatorenal Syndrome;   Refractory Ascites
Interventions: Drug: Midodrine, albumin, octreotide LAR;   Drug: midodrine, octreotide, albumin
13 Recruiting Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
Conditions: Cirrhosis;   Hepatorenal Syndrome
Interventions: Drug: Terlipressin plus albumin;   Drug: Midodrine plus octreotide plus human albumin
14 Completed A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea
Conditions: Diarrhea;   HIV Infections
Intervention: Drug: Octreotide
15 Active, not recruiting Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
Conditions: Peritoneal Neoplasms;   Intestinal Obstruction;   Carcinomatosis
Intervention: Drug: Octreotide
16 Recruiting Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
Condition: Thymoma
Intervention: Drug: Octreotide
17 Recruiting Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
Condition: Migraine Headache
Intervention: Drug: Octreotide
18 Completed Evaluation of the Efficacy of Long-Acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma
Condition: Advanced Hepatocellular Carcinoma
Intervention: Drug: Octreotide
19 Active, not recruiting Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
Condition: Neuroendocrine Tumors
Intervention: Drug: Octreotide
20 Recruiting Safety and Efficacy of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease
Condition: Carcinoid Disease
Interventions: Drug: Pasireotide;   Drug: Octreotide

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services